Back to Rankings

CDNA

CareDxA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
The constructive read is that Q1 confirmed strong transplant-testing demand, improved collections, and operating leverage, while management simultaneously raised 2026 guidance and advanced strategic portfolio actions. Delayed analyst reaction was thin but supportive, with BTIG raising its target to $28 from $26 on April 29, 2026 after the oncology diagnostics deal.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -4.0.
What can break
CareDx had previously embedded an estimated Medicare LCD headwind in 2026 planning, so reimbursement remains a monitoring risk even after the guide raise.
Momentum
77
Value
50
Sentiment
59
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $25.20 · Bull $28.00 · Bear $18.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $25.17
Why
Momentum77 · Δ7d -4.0
Value50 · Δ7d -0.1
Sentiment59 · Δ7d -2.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
77
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.0
Δ21d
-13.4
Value
50
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.1
Sentiment
59
33% active weight
Current posture
7d trendSoftening
Δ7d
-2.8
Δ21d
+2.1
Why this grade

Composite grade A. Momentum 76.9 / Value 50.1 / Sentiment 59.4

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.18B
Beta
2.51
Shares Out
51.43M
P/E (TTM)
24.6
P/S (TTM)
2.85
P/FCF (TTM)
27.98
Rev YoY
+20.7%
EPS YoY
+115.5%
Gross Margin
+67.6%
Op Margin
+14.0%
Net Debt
-$260.65M
Current Ratio
3.03
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology